Cite
HARVARD Citation
Yazici, Y. et al. (n.d.). SAT0552 Clinical outcomes from a randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, injectable, WNT pathway inhibitor (SM04690) for the treatment of knee osteoarthritis: week 26 interim analysis. Annals of the rheumatic diseases. pp. 985-986. [Online].